The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
NCT03641950
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
249
Enrollment
INDUSTRY
Sponsor class
Conditions
Essential Blepharospasm
Interventions
DRUG:
Botulinum toxin type A
Sponsor
Hugel